Biomet buyers begin tender offer
The group of private-equity firms that last week sweetened its offer to buy Biomet Inc. today began a tender offer to buy the Warsaw medical device maker’s shares for about $11.4 billion. The offer of $46 a share, which expires July 11, is contingent upon at least 75 percent of all shares being tendered. A […]